To be specific, in ACC, BLCA, KIRC, and KIRP tissues, APOBEC3B RNA expression levels were consistently associated with later clinical stages; in CHOL, LIHC, and OV mRNA expression level of APOBEC3B was significantly higher in the early stage of these diseases. This evidence concerns the gene APOBEC3B and bladder transitional cell carcinoma.